Skip to content
Austin Top 50
Author:
BitMEX
BitMEX Integrates with Banxa to Expand On and Off-Ramp Offerings
June 4, 2026
BitMEX and COLLYBUS Announce Strategic Platform Partnership to Deliver Institutional-Grade Trading Technology
May 26, 2026
Johnson & Johnson investigational co-antibody therapy JNJ-4804 shows potential to raise the bar for clinical efficacy in treating refractory inflammatory bowel disease
May 16, 2026
Johnson & Johnson study shows TREMFYA® (guselkumab) is the first and only IL-23 inhibitor to demonstrate efficacy in perianal fistulizing Crohn’s disease
May 16, 2026
BitMEX Expands TradFi Perpetual Swaps with FX for 24/7 Crypto Trading
April 29, 2026
BitMEX Launches the Trading Circuit Campaign Featuring a 100,000 USDT Weekly Prize Pool
April 22, 2026
BitMEX Launches the 24/7 TradFi Campaign Featuring a 50,000 USDT Prize Pool
April 16, 2026
BitMEX Report Finds 500%+ Increase in Tokenised Commodities and Equity Perpetuals
April 9, 2026
ICOTYDE™ (icotrokinra) one-year results confirm lasting skin clearance and favorable safety profile in once‑daily pill for plaque psoriasis
March 30, 2026
FDA approval of ICOTYDE™ (icotrokinra) ushers in new era for first-line systemic treatment of plaque psoriasis with a targeted oral peptide
March 18, 2026
1
2
Next Page
→